The Golden Age of IPOs is Here: IPOX's Schuster

SpaceX is preparing a potential $75 billion IPO, offering 555.6 million shares at $135 each, with trading set to begin on June 12. If completed at that valuation, it would be the largest IPO ever, surpassing Saudi Aramco's $29.4 billion listing in 2019. The deal is a major milestone for private markets and late-stage technology financing.

Analysis

This deal is less about one company’s valuation and more about a redistribution of private-market optionality into public-market liquidity. A print this large will likely become the reference point for late-stage growth multiples across defense, AI infrastructure, and deep-tech venture assets, forcing a repricing of everything from secondary transactions to crossover fund marks. The immediate winners are not just employees and early holders monetizing at scale, but also late-stage investors who can now point to a cleared exit path for mega-cap private names.

The second-order effect is on capital formation: once the market absorbs a $75B-style listing, every large private issuer will face higher scrutiny on governance, disclosure, and post-IPO cadence, which should widen dispersion between truly scarce assets and “story stock” adjacent names. That tends to hurt venture capital funds dependent on high headline marks, while helping public-market brokers, lockup hedgers, and liquidity providers around the event window. It also raises the bar for competing private-space and defense platforms, which may need to accelerate fundraising or partnership announcements to avoid relative underperformance.

Risk is mostly timing-based. In the first days and weeks, the main failure mode is not fundamental weakness but supply overhang: a record-setting deal can become a sentiment peak if post-listing demand is absorbed too quickly or if insiders signal more monetization ahead. Over a 3-12 month horizon, the real catalyst is whether the company can sustain scarcity-premium valuation after the novelty fades; if not, the market may treat this as an exceptional transaction rather than a durable rerating for the entire innovation complex.

The contrarian angle is that the ‘biggest IPO ever’ framing may be a local top signal for private-market euphoria, not a confirmation of strength. When size itself becomes the headline, the market often confuses liquidity with quality; the cleaner trade is to fade the adjacent exuberance rather than the deal itself.

Key Decisions for Investors

• Short overextended late-stage VC proxies and private-market access vehicles into the IPO window; look for 2-6 week mean reversion as the market digests record issuance and secondary supply.
• Pair trade: long public-market liquidity beneficiaries vs short private-markets sentiment beta. Use brokerage/exchange names with secondary trading exposure against a basket of high-multiple venture/late-stage crossover proxies; 1-3 month horizon.
• Buy downside protection on the broad innovation complex via puts on high-beta tech or venture-adjacent indices into the first week of trading; structure as a defined-risk hedge against a post-deal sentiment unwind.
• If you have exposure to private defense/space names, trim 20-30% on strength over the next 1-2 months; this listing raises the bar for scarcity premium and can compress valuation dispersion.
• For opportunistic traders, fade the first 48-72 hours of momentum only if opening-day demand is extreme; use a tight stop because record IPOs can stay irrational longer than expected, but upside from chasing after initial pricing is typically poorer than waiting for lockup dynamics.